Expression and function of NOD-like receptors by human term gestation-associated tissues by Aled, Bryant & Catherine, Thornton
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in:
Placenta
                           
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa34833
_____________________________________________________________
 
Paper:
Bryant, A., Bevan, R., Spencer-Harty, S., Scott, L., Jones, R. & Thornton, C. (2017).  Expression and function of NOD-
like receptors by human term gestation-associated tissues. Placenta, 58, 25-32.
http://dx.doi.org/10.1016/j.placenta.2017.07.017
 
 
 
 
 
 
Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-
ND). 
 
_____________________________________________________________
  
This item is brought to you by Swansea University. Any person downloading material is agreeing to abide by the terms
of the repository licence. Copies of full text items may be used or reproduced in any format or medium, without prior
permission for personal research or study, educational or non-commercial purposes only. The copyright for any work
remains with the original author unless otherwise specified. The full-text must not be sold in any format or medium
without the formal permission of the copyright holder.
 
Permission for multiple reproductions should be obtained from the original author.
 
Authors are personally responsible for adhering to copyright and publisher restrictions when uploading content to the
repository.
 
http://www.swansea.ac.uk/library/researchsupport/ris-support/ 
 1 
 
Title: Expression and function of NOD-like receptors by human term gestation-associated tissues 1 
 2 
Short title: NLRs at the materno-fetal interface 3 
 4 
Authors: Aled H Bryant1, Ryan J Bevan1, Samantha Spencer-Harty2, Louis M Scott1, Ruth H Jones1, 5 
Catherine A Thornton1,3 6 
 7 
1 Institute of Life Science, Swansea University Medical School, Swansea, Wales, UK 8 
2 Histopathology Department, Singleton Hospital, Abertawe Bro Morgannwg University Health 9 
Board, Swansea, Wales, UK 10 
3 Corresponding Author: Professor Cathy Thornton  11 
E-mail c.a.thornton@swansea.ac.uk, Telephone: 01792 602122.  12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
Abstract 20 
Introduction: Nucleotide-binding oligomerization domain (NOD)-like receptors or NOD-like 21 
receptors (NLRs) have been implicated in several disease pathologies associated with inflammation. 22 
2 
 
Since local and systemic inflammation is a hallmark of both term and preterm labour, a role for NLRs 23 
at the materno-fetal interface has been postulated.  24 
Methods: Gene expression and immunolocalisation of NLR family members in human placenta, 25 
choriodecidua, and amnion were examined. Tissue explants were used to examine the response to 26 
activators of NOD1 (Tri-DAP), NOD2 (MDP) and NLRP3 (nigericin). Cell/tissue-free supernatants 27 
were examined for the production of interleukin (IL)-1β, IL-6, IL-8 and IL-10 using specific ELISAs.  28 
Results: Expression of transcripts for NOD1, NOD2, NLRP3, NLRC4, NLRX1, NLRP1 and NAIP and 29 
protein expression of NOD1, NOD2 and NLRP3 were a broad feature of all term gestation-associated 30 
tissues. Production of cytokines was increased significantly in response to all ligands in placenta and 31 
choriodecidua, except for MDP-induced IL-10. Similarly, there was a significant increase in cytokine 32 
production in the amnion except for MDP induced IL-1β and IL-10 response to either agonist. IL-1β 33 
production was dependent on caspase-1 regardless of agonist used or tissue examined. 34 
Discussion: Term human gestation-associated tissues express functional NLRs which likely play a 35 
role in both sterile and pathogen-driven inflammatory responses at the materno-fetal interface. 36 
 37 
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Introduction 48 
Nucleotide-binding oligomerization domain-like receptors, or NOD-like receptors (NLRs), are a 49 
family of intracellular pattern recognition receptors (PRRs). They are involved in the recognition of 50 
both pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns 51 
(DAMPs) that have entered the cell [1]. Numerous NLRs have been described and they are divided 52 
into five subfamilies based on their N-terminal domain [1].  The first identified and most widely 53 
studied NLRs are NOD1 and NOD2 [2]. NOD1 and NOD2 recognise structures within bacterial 54 
peptidoglycan; NOD1 recognises iE-DAP and Tri-DAP specific to Gram-negative bacteria, whereas  55 
NOD recognises MDP, common to both Gram-negative and -positive bacteria [2]. Certain members 56 
of the NLR family, including NLRP1 and NLRP3, following the detection of PAMPs or DAMPs 57 
trigger the assembly of a large caspase 1 activating complex termed the inflammasome which enables 58 
the processing and secretion of pro-forms of IL-1β and IL-18 [3].  59 
 60 
Preterm birth (PTB) is the leading cause of perinatal morbidity and mortality in the Western world. 61 
Intrauterine infection is a common mechanism of preterm labour but the role of damage in this 62 
pathology is becoming increasingly apparent [4]. As the common outcome of both PAMP and DAMP 63 
signals is local and systemic inflammation, a role for PRRs in the pathophysiology of preterm labour 64 
and birth has long been suggested [5]. It is increasingly apparent that NLRs play a role in several 65 
disease pathologies associated with inflammation [6,7] so a role for NLRs in preterm labour and other 66 
adverse pregnancy outcomes would not be unexpected.  67 
 68 
NOD1 and NOD2 expression by term human decidua and only NOD1 expression in term amnion 69 
epithelial cells have been reported [8]. Functionally, NOD1 and NOD2 activity have been observed in 70 
total fetal membrane explants [9], but NLR activity by separated amnion and choriodecidua has not 71 
been examined to date. For the placenta, NOD1 but not NOD2 has been reported as expressed and 72 
functional in term trophoblast cells, whereas in first trimester placental trophoblast both NOD2 and 73 
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NOD1 are expressed with corresponding functional output [10]. However, several other cell 74 
populations are present within the placenta that would likely contribute to the inflammatory profile of 75 
this organ. Expression of transcripts for NLRP3 by first trimester placenta has been observed [11], 76 
and a functional response in the first trimester trophoblast cell line Sw.71 and term cytotrophoblasts to 77 
uric acid, a NLRP3 activator, has also been noted [12-14]. Term fetal membranes show expression of 78 
NLRP3 with a functional response observed in explants treated with the NLRP3 activators ATP and 79 
nigericin [15]. 80 
 81 
Our objective was to increase understanding of the possible role of NLRs in a reproductive setting by 82 
examining the expression and functional activity of the NLRs simultaneously in term placenta, 83 
choriodecidua and amnion. Where possible, functional activity was examined using an explant model 84 
to better mimic the cellular heterogeneity that occurs in utero. 85 
 86 
 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
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Materials and Methods 95 
Samples 96 
Placenta and fetal membrane samples were collected from healthy term newborns (>37 weeks of 97 
gestation) delivered by elective caesarean section at Singleton Hospital, Swansea, UK. Informed, 98 
written consent was obtained from all study participants following recruitment at the antenatal day 99 
assessment unit. Ethical approval for this study was given by Wales Research Ethics Committee 6 100 
(REC No. 11/WA/0040).  101 
 102 
Explant Cultures 103 
Placenta. Placental explant cultures were prepared as described previously [16,17]. Briefly, the 104 
overlaying decidua basalis of the maternal side of the placenta was removed and 1 cm3 pieces of 105 
placenta tissue were cut from various sites and placed into sterile calcium and magnesium free 106 
phosphate buffered saline (PBS; Life Technologies, UK). Tissue was washed repeatedly with PBS to 107 
remove contaminating blood. Tissue was then minced into smaller pieces and washed further. Pieces 108 
of tissue (1mm3 pieces to a total of 0.2 g) were cultured in UltraCULTURE medium (Lonza, 109 
Switzerland), supplemented with 2 mM GlutaMAX (Life Technologies, UK) and 2 mM penicillin, 110 
streptomycin, Fungizone (PSF; Life Technologies, UK).  111 
 112 
Membranes. Membranes were detached from the placenta. Choriodecidua and amnion were separated 113 
from each other by blunt dissection and placed individually into PBS. Tissue was washed repeatedly 114 
with PBS to remove any contaminating blood. Each membrane was cut with an 8mm biopsy punch 115 
(Stiefel, Medisave, UK). Two biopsies of choriodecidua were cultured in 0.5 ml of Advanced RPMI 116 
(Life Technologies, UK) supplemented with 2 mM GlutaMAX, 2% FBS (HyClone; Thermo Fisher 117 
Scientific, UK) 2 mM PSF and 5mM 2-mercaptoethanol (2-ME; Thermo Fisher Scientific). Three 118 
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biopsies of amnion were cultured in 0.5 ml of Advanced DMEM (Life Technologies, UK) 119 
supplemented with 2 mM GlutaMAX, 2% FBS and 2 mM PSF. 120 
 121 
Once prepared, explant cultures were exposed to different stimuli with an unstimulated control always 122 
included. Optimal levels of all agonists were determined by dose course experiments on gestation-123 
associated tissues explants and the following final concentrations were used; Tri-DAP (NOD1, 10 124 
µg/ml), MDP (NOD2, 10 µg/ml), LPS (10 ng/ml) and nigericin (1µM) (all from Invivogen, USA). 125 
For inhibition experiments, cultures were treated with an inhibitor of caspase-1 (Z-WEHD-FMK, 5 126 
µM; R&D systems) 30 min before the addition of Tri-DAP, MDP or nigericin. Cellular cytotoxicity 127 
was not observed with addition of inhibitors (data not shown) as determined by lactate dehydrogenase 128 
assay (Abcam). All treatments were performed in duplicate. Cultures were incubated for 24 hours at 129 
37°C in 5% CO2. Tissue free supernatants were collected by centrifugation for 7 minutes at 4°C, 515 130 
x g and stored at -20°C for analysis using cytokine specific ELISAs. 131 
 132 
Cytokine production 133 
Levels of IL-1β, IL-6, IL-8 and IL-10 in tissue free supernatants of placenta, choriodecidua and 134 
amnion explant cultures collected after 24 h were measured using commercially available ELISA kits 135 
(DuoSet, R&D Systems) as per manufacturer’s instructions. 136 
 137 
RNA Extraction from Gestation-Associated Tissue Samples 138 
Biopsies of tissue were preserved in TRI reagent (Sigma-Aldrich, UK) at -20°C. DNA-free RNA was 139 
prepared from homogenised tissue (FastPrep FP120A Homogeniser; Qbiogene, The Netherlands) 140 
following the TRIzol method of extraction and DNA-free DNase kit (Ambion®, Thermo Fisher 141 
Scientific, UK) as per manufacturer’s instructions. Purity and concentration of RNA were measured 142 
(NanoDrop 3300 flurospectrometer; NanoDrop Technologies, USA).  143 
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 144 
Polymerase Chain Reaction (PCR) 145 
Reverse transcription was performed using the RETROscript kit (Ambion®, Thermo Fisher 146 
Scientific, UK) as per manufacturer’s instructions. Polymerase chain reaction was performed using 147 
the Platinum® Taq DNA Polymerase kit and dNTP Mix (both Thermo Fisher Scientific, UK). All 148 
primers were synthesised by Thermo Fisher Scientific, using sequences obtained using primer BLAST 149 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). UBE2D2 housekeeping primers were based on 150 
previously published sequences [18]. Primer sequences and specific conditions for each PCR are 151 
listed in Table 1.   152 
 153 
Immunohistochemistry 154 
Immunohistochemical staining for NOD1, NOD2 and NLRP3 was performed on formalin fixed, 155 
paraffin embedded sections (4 µm) of placenta and fetal membranes using the Ventana ULTRA 156 
automated staining instrument as described previously (24). The following modifications were made: 157 
Optiview detection system was used without A/B blocker or amplification, antigen retrieval was 158 
carried out in CC1 buffer for 16 minutes for both NOD1 and NLRP3, and in protease 1 for 8 minutes 159 
for NOD2.   Mouse monoclonal anti-NOD1 (10 µg/ml; R&D Systems, USA), rabbit polyclonal anti-160 
NOD2 (3 µg/ml; LifeSpan BioSciences, Inc, USA) and mouse monoclonal anti-NLRP3 (10 µg/ml; 161 
Abcam, USA) were incubated at 36°C for 40, 24 and 36 minutes, respectively. For control slides, 162 
primary antibody was replaced with either rabbit IgG (3 µg/ml; Biolegend), mouse IgG1 (10 µg/ml; 163 
eBioscience), or mouse IgG2b (10 µg/ml; eBioscience) isotype controls at the same concentration. 164 
 165 
Data analysis 166 
All experiments were performed a minimum of three times. Cytokine production by non-laboured 167 
tissues was evaluated using repeated measures one-way ANOVA with Dunnett’s multiple comparison 168 
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test. A p-value of ≤ 0.05 was considered significant. Statistical significance was calculated using 169 
GraphPad Prism (Version 6, GraphPad Software Inc, USA).  170 
 171 
 172 
 173 
 174 
 175 
 176 
 177 
Results 178 
Expression of transcripts of NLRs by gestation-associated tissues 179 
PCR analysis revealed expression of transcripts for NOD1, NOD2, NLRP3, NLRC4, NLRX1, NLRP1 180 
and NAIP in all gestation-associated tissues studied. PCR was performed using five individual 181 
samples of each tissue type (placenta, choriodecidua and amnion); three of these five samples are 182 
shown (Figure 1). Transcripts for each NLR examined were present in all five samples of each of the 183 
tissues.  184 
 185 
Immunolocalisation and function of NOD1 and NOD2 by gestation-associated tissues  186 
Expression of NOD1 and NOD2 was examined using immunohistochemistry (Figure 2A). In the 187 
placenta, expression of NOD1 was localised to the syncytiotrophoblast, while NOD2 expression was 188 
present in the syncytiotrophoblast and cells within the stroma. In the fetal membranes both NOD1 and 189 
NOD2 expression were present in the amnion epithelial cells, chorionic trophoblast and cells within 190 
the decidua. This expression pattern was similar for all 7 samples studied.  191 
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 192 
To investigate if NOD1 and NOD2 were functional, the agonists L-Ala-γ-D-Glu-mDAP (Tri-DAP; 193 
NOD1, 10 µg/ml) and muramyl dipeptide (MDP; NOD2, 10 µg/ml) were used. Both Tri-DAP and 194 
MDP induced a significant increase in IL-1β, IL-6, IL-8 and IL-10 by the placenta (Figure 3A). A 195 
significant increase in both IL-6 and IL-8 in response to NOD1 and NOD2 activation also was a 196 
common feature of both the choriodecidua and amnion (Figure 3B and C). Both Tri-DAP and MDP 197 
induced significant IL-1β by choriodecidua, however only Tri-DAP induced a significant IL-10 198 
response (Figure 3C). With regards to the amnion, treatment with Tri-DAP induced significant IL-1β 199 
and IL-10, however MDP did not induce IL-1β above background and there was no significant effect 200 
on IL-10 production (Figure 3C). 201 
 202 
Immunolocalisation and function of NLRP3 by gestation-associated tissues  203 
NLRP3 expression was examined using immunohistochemistry (Figure 4A). In the placenta, 204 
expression of NLRP3 was localised primarily to syncytiotrophoblast and cells within the stroma. In 205 
the fetal membranes, NLRP3 was expressed by the chorionic trophoblast, cells within the decidua and 206 
amnion epithelial cells. For all tissues NLRP3 reactivity appeared to be localised to the nucleus. 207 
Tissue samples from seven different donors were studied and all were positive for NLRP3. However, 208 
while there was little variability in intensity of NLRP3 reactivity within the fetal membranes there 209 
were noticeable differences in the placenta and this seems to be inversely correlated to maternal BMI 210 
(Supplementary Figure 1).  211 
 212 
To investigate if the NLRP3 inflammasome was functional, the potassium ionophore nigericin (1µM) 213 
derived from Streptomyces hygroscopicus was used. Prior to the addition of nigericin tissue explants 214 
were primed with LPS (10 ng/ml) for 3 hours. A significant increase in IL-1β, above both background 215 
and LPS treatment alone, was observed for each tissue following exposure to nigericin (Figure 4B-D). 216 
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 217 
NLR induced IL-1β production is caspase-1 dependent 218 
As the production and secretion of IL-1β following NLRP3 activation is reliant on caspase-1, a 219 
caspase-1 inhibitor was utilized to confirm the involvement of the NLRP3 inflammasome. This 220 
approach was also applied to explants treated with both Tri-DAP and MDP due to the robust IL-1β 221 
response observed. In the presence of capase-1 inhibitor, both Tri-DAP- and MDP-induced IL-1β 222 
levels were inhibited in the placenta (Figure 5A), choriodecidua (Figure 5B) and amnion (Tri-DAP 223 
only; Figure 5C). A decrease in IL-1β in the presence of capase-1 inhibitor was also observed for 224 
treatment with both LPS alone and LPS and nigericin in all tissues examined (Figure 5D-F). 225 
 226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
 234 
 235 
 236 
 237 
Discussion 238 
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Inflammation caused by infection or damage is a common feature of various pathologies [4] and 239 
NLRs have been implicated to have a role. Since a hallmark of both term and preterm labour is local 240 
and systemic inflammation a role for NLRs at the materno-fetal interface has been postulated [5]. 241 
Here we demonstrate that specific agonists for the NLRs - NOD1, NOD2 and NLRP3 - generate 242 
cytokine production by the placenta, choriodecidua and amnion, corresponding to expression at both 243 
the gene and protein level. Additionally, expression of transcripts of other NLRs, namely NLRC4, 244 
NLRX1, NLRP1 and NAIP by term gestation-associated tissues been demonstrated for the first time. 245 
 246 
Previous investigations of NOD expression by the placenta have been limited to primary first and 247 
third trimester trophoblast. Transcripts and protein for both NOD1 and NOD2 were found in first 248 
trimester trophoblast but only for NOD1 in third trimester trophoblast with a corresponding functional 249 
response [19,20]. Here we demonstrate that transcripts and protein for both NOD1 and NOD2 are 250 
present in the term placenta. Furthermore, treatment of placental explants with Tri-DAP (NOD1) and 251 
MDP (NOD2) resulted in increased cytokine production (IL-1β, IL-6, IL-8 and IL-10) implying that 252 
both receptors are functional. Increases in pro-inflammatory cytokines are not unexpected as both Tri-253 
DAP and MDP are known initiators of inflammation. The increase in the anti-inflammatory cytokine 254 
IL-10 might represent a compensatory mechanism: concentrations of anti-inflammatory cytokines are 255 
increased in the amniotic fluid from women who delivered preterm and had evidence of intra-256 
amniotic infection  [21] possibly representing a failed compensatory mechanism [22].  Discrepancies 257 
in NOD2 expression and function might be related to the model of investigation used, i.e. a 258 
dissociated cell culture model focussing on trophoblast only [19,20] in comparison to explants as 259 
here. The placenta is heterogeneous, composed of many cell types such as cytotrophoblast, 260 
syncytiotrophoblast, mesenchymal stem cells, endothelial cells and macrophages (Hofbauer cells). It 261 
is possible that other non-trophoblast cell types within the placenta are responsible for both NOD2 262 
expression and activity as observed by us. For example, both monocyte derived macrophages 263 
(MDMs) [23] and tissue-resident macrophages [24,25] express NOD2 in humans. 264 
Immunohistochemistry of NOD1 and NOD2 expression revealed this to be the case. NOD1 265 
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expression within the placenta was localised to syncytiotrophoblast cells while NOD2 was expressed 266 
in both syncytiotrophoblast and other cells within the stroma. This observation of NOD2 expression 267 
by trophoblast cells of the term placenta clearly differs from previous reports where the MDP-268 
stimulated IL-8 response in term cytotrophoblast lacking NOD2 expression was described as NOD2-269 
independent [19].  270 
 271 
MDP can also activate human NLRP1 [26] which is involved primarily in inflammasome activity 272 
typically measured via IL-1β output. Transcripts for NLRP1 have been reported in first trimester 273 
trophoblast in addition to decidual stroma and endothelial cells [11]. We found transcripts for both 274 
NLRP1 as well as other inflammasome-associated NLRs, namely NLRP3, NLRC4 and NAIP, in the 275 
term placenta. MDP was also able to induce IL-1β production in the placenta in a caspase-1 dependent 276 
manner. IL-1β production by MDP treated trophoblasts, either first or third trimester, has not been 277 
reported [10,19] and since transcripts for NLRP1 are present, it is possible that the NOD2-278 
independent IL-8 observed [27,28] might relate to autocrine exposure to IL-1β. 279 
 280 
NOD1 and NOD2 expression and responsiveness have been reported in the fetal membranes with 281 
NOD1 and NOD2 protein expressed by chorionic cytotrophoblasts and decidual cells but only NOD1 282 
by amnion epithelial cells; both receptors were up-regulated following spontaneous labour [8]. In 283 
contrast, we found NOD1 and NOD2 protein expression using immunohistochemistry in cells of the 284 
amnion, chorion and decidua. Term choriodecidua and amnion both produced IL-6 and IL-8 in 285 
response to Tri-DAP and MDP treatment, corresponding to term fetal membrane explants treated with 286 
iE-DAP (NOD1) and MDP [8]. Additionally, we demonstrated that the choriodecidua produces IL-1β 287 
in response to both Tri-DAP and MDP, and IL-10 in response to Tri-DAP. The amnion produced IL-288 
1β in response to Tri-DAP treatment, while neither Tri-DAP nor MDP treatment resulted in a 289 
significant IL-10 response. The caspase-1 dependence of Tri-DAP and/or MDP IL-1β production by 290 
the choriodecidua and amnion was confirmed. The balance of pro and anti-inflammatory cytokines 291 
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observed in the choriodecidua, mimics that of the placenta, suggesting a similar functional activity of 292 
NLRs in these tissues. However, while the amnion has both functional NOD2 and NLRP3 and active 293 
caspase-1, its unknown why activation with MDP does not result in an IL-1β response. MDP induced 294 
IL-1β might require the activity of other initiator caspases in the amnion.  295 
 296 
NLRP3 expression in term placenta was localised primarily to the syncytiotrophoblast in keeping with 297 
the observation of NLRP3 gene expression by first trimester trophoblasts [11]. NLRP3 expression 298 
was noted in all samples studied but there was variability in this. NLRP3 expression and subsequent 299 
inflammasome activation can be affected by several different factors including smoking status [30], 300 
obesity [31] and age [32]. In our study, the expression of placental NLRP3 seemed to correlate 301 
negatively with BMI, i.e. decreasing NLRP3 expression with increasing maternal BMI. This contrasts 302 
with a previously published report of a positive correlation of trophoblast produced IL-1β with 303 
maternal BMI, though caspase-1 signalling was unaffected [33]. However, with only seven samples 304 
included in our study, caution should be taken until more samples can be examined (supplementary 305 
figure 1). Expression of NLRP3 was also observed by both the amnion and choriodecidua, however 306 
unlike the placenta, expression of NLRP3 was constant between donors. This observation of NLRP3 307 
expression is in keeping previous reports [35] but we noted that NLRP3 expression was 308 
predominantly nuclear. While typically considered a cytoplasmic protein, NLRP3 has been shown to 309 
function as a nuclear transcription factor, positively regulating Th2 immunity, independent of 310 
inflammasome activity [36]. Nuclear translocation of NLRP3 might have a role in placental regulation 311 
of the Th2 predominance in pregnancy [37]. With a negative correlation between placental NLRP3 312 
expression and maternal BMI, the loss of a NLRP3 driven Th2 environment might explain the 313 
increased inflammatory environment in obese pregnant women and the associated risk of adverse 314 
pregnancy outcomes [34]. 315 
 316 
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Activation of the NLRP3 inflammasome by DAMPs, such as uric acid crystals or ATP, is associated 317 
with a “two-step” mode of activation [3]. Here functional placental NLRP3 is shown using an LPS 318 
prime (signal 1) and the potassium ionophore nigericin (signal 2) to give a significant increase in the 319 
production of IL-1β in a caspase-1 dependent manner. Previous studies have produced an IL-1β 320 
response in the first trimester trophoblast cell line Sw.71 [12,13] and term cytotrophoblasts [14] using 321 
uric acid crystals, although no priming signal was used in these studies. Caspase-1 dependent IL-1β 322 
production in response to nigericin was also observed by the choriodecidua and amnion, 323 
corresponding to IL-1β production by fetal membrane explants in response to ATP treatment [15,38]. 324 
 325 
In addition to NOD1, NOD2 and NLRP3, we have also shown that term placenta, choriodecidua and 326 
amnion express transcripts for NLRC4, NLRX1, NLRP1, and NAIP. Gene expression of NLRP1 and 327 
NAIP by the placenta [39] and gene and protein expression of NRLP1 and NLRC4 by term fetal 328 
membranes [35] has been reported by others. This is however the first report of placental NLRC4, 329 
fetal membranes NAIP expression, and NLRX1 expression by all three gestation-associated tissues. 330 
Furthermore while we have focussed on the casapase-1 dependence of IL-1β production, several other 331 
caspases (caspase-4, -5, -8 and -12) can either directly, by canonical and non-canonical 332 
inflammasomes, or indirectly modulate the production of IL-1β [40]. Functional activity of these 333 
NLRs and other caspases by gestation-associated tissues is still to be examined with our recent work 334 
showing a contribution of Caspases-1, -4 and -8 to IL-1β production in placenta, choriodecidua and 335 
amnion (Scott et al. Cytokine. Accepted). 336 
 337 
The role of NLRs, especially through the production of IL-1β, highlights a potential role for this 338 
family of PRRs in the inflammation that occurs with preterm birth [41]. This inflammation can be 339 
driven by PAMPs or DAMPs but has common downstream outcomes related to chorioamnionitis, 340 
fetal membrane rupture, cervical ripening, and parturition [5,41]. Better understanding of the 341 
expression and activity of NLRs in adverse pregnancy outcomes is now required.  342 
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Table Legends 463 
Table 1. Sequences and optimum conditions for each pair of NOD-like receptor (NLR) primers used 464 
for RT-PCR. 465 
 466 
Figure Legends 467 
Figure 1. Gene Expression of NLRs by term non-laboured gestation-associated tissues. RT-PCR 468 
for NOD1, NOD2, NLRP3, NLRC4, NLRX1, NLRP1 and NAIP. Three representative samples of 5 469 
are shown. Human spleen (S) was used as a positive control and UBE2D2 was used as a 470 
housekeeping gene. L = 100 base pair ladder and the negative control (-ve) was with water replacing 471 
cDNA in the reaction mix. 472 
Figure 2. Protein expression of NOD1 and NOD2 in human gestation-associated tissues. 473 
Immunolocalisation of NOD1 and NOD2 in placenta and fetal membranes. Negative (isotype match) 474 
and positive (NOD1; tonsil and NOD2; colon) controls are also displayed. A representative example 475 
of 7 is shown.  476 
 477 
Figure 3. Functional response of human gestation-associated tissues to NOD1 and NOD2 478 
agonists. NOD1/2 agonist induced cytokine response by term non-laboured placenta, choriodecidua 479 
and amnion. IL-6, IL-8, IL-10 and IL-1β production (mean ± SEM) by the (A) placenta, (B) 480 
choriodecidua, and (C) amnion following stimulation with 10 μg/ml Tri-DAP or MDP (n=6). 481 
Statistically significant differences compared to unstimulated control are shown: * p< 0.05, ** 482 
p<0.01, *** p< 0.001. 483 
 484 
Figure 4. Expression and functional response of NLRP3 in human gestation-associated tissues. 485 
(A) Immunolocalisation of NLRP3 in placenta and fetal membranes. Negative (isotype match) and 486 
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positive (tonsil) controls are also displayed. Representative examples of 7 are shown; placenta 1 is 487 
from a woman of normal weight woman; placenta 2 is form a morbidly obese woman. (B-D) 488 
Nigericin-induced IL-1β (mean ± SEM) response by term non-laboured (B) placenta, (C) 489 
choriodecidua and (D) amnion. Statistically significant differences compared to unstimulated control 490 
are shown: * p< 0.05, ** p<0.01.  491 
 492 
Figure 5. Caspase-1 is required for NLR-induced IL-1β production by gestation-associated 493 
tissues. IL-1β production from explants of (A & D) placenta, (B & E) choriodecidua and (C & F) 494 
amnion in response to Tri-DAP, MDP (A-C) or nigericin (D-F) pre-treated for 30 minutes with 495 
caspase-1 inhibitor (Z-WEHD-FMK; 5 µM) or vehicle control (n=3). Statistically significant 496 
differences compared to unstimulated control are shown: * p< 0.05, ** p<0.01, *** p< 0.001, **** p< 497 
0.0001. 498 
 499 
Supplementary Figure Legends 500 
 501 
Figure S1.  Immunolocalisation of NLRP3 in placenta is negatively correlated with body mass 502 
index.  503 
Immunohistochemical staining for NLRP3 performed on formalin fixed, paraffin embedded sections 504 
(4 µm) of placenta using mouse monoclonal anti-NLRP3 (10 µg/ml; Abcam, USA).  505 
 506 
 507 
 508 
 509 
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TABLE 1 
 
Gene Primer 
Mg2+     
Conc 
(nM) 
Annealing 
Temp (°C) 
Fragment 
Size (Bp) Accession Number 
NOD1 
F 5' AGGCTGAGTACCATGGGCTA 
2 66 184 NM_006092 
R 5' GCCCGTTTAGTCACCCTTCA 
NOD2 
F 5' CAGGCAGCACAGGTCAGCCC 
2 71 300 NM_001293557 
R 5' GTTGTGCGGCTCGGCCTTCT 
NLRP1 
F 5' ATACGAAGCCTTTGGGGACT 
3 65 164 NM_014922 
R 5' CACCGCTTCTCTCATCACAA 
NLRP3 
F 5' ACCGGAGCCAGCAGGAGAGG 
1.5 71 659 NM_001127461  
R 5' GAAGGCTGCCCTGGCTTGGG 
NLRC4 
F 5' GCCTCAGGCTGCAAATAAAG 
2 68 213 NM_001199139 
R 5' CCAAGCTGTCAGTCAGACCA 
NLRX1 
F 5' GCTCCATGGCTTAGAGCATC 
1.5 62 189 NM_001282358  
R 5' ACGTACTTGCTGGGGATACG 
NAIP F 5' TTCTTGCCCTGAAAACTGCT 3 66 169 NM_004536  
22 
 
R 5' CGTATTGGGAAGTGGATGCT 
UBE2D2 
F 5' GATCACAGTGGTCTCCAGCA 
3nM 65°C 156 Popov et al 2010 
R 5' TCCATTCCCGAGCTATTCTG 
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